cd38 inhibitor and 5-amino-1mq synergy nad+ CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents Targeting NAD+ Synthesis to Potentiate
Targeting NAD+ Synthesis to Potentiate CD38 Based Immunotherapy of Multiple Myeloma ScienceDirect Heavy chain antibody targeting of CD38 NAD+ hydrolase ectoenzyme to prevent fibrosis in multiple organs Scientific Reports Frontiers Nicotinamide N methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome CD38 is a key mediator of NAD+ depletion in the brain of ZIKV infected mice: iScience Inhibition of CD38 enzymatic activity enhances CAR T cell immune therapeutic efficacy by repressing glycolytic metabolism ScienceDirect Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide induced microglial and astrocytic neuroinflammation by increasing NAD+ PMC
Pay in 4 interest-free payments of $6.51 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6





